Showing results (221-230 of 3,095) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|March 11, 2010
Fusion imaging for parathyroid localization in primary hyperparathyroidismDaniel S Levine, Sam M WisemanExpert Review of Anticancer Therapy|August 23, 2016
Renal cell cancer: overview of the current therapeutic landscapeMustafa Erman, Mustafa Benekli, Mert Basaran, et al.Expert Review of Anticancer Therapy|April 11, 2018
The role of neoadjuvant chemotherapy in ovarian cancerAntoine Elies, Sophie Rivière, Nicolas Pouget, et al.Expert Review of Anticancer Therapy|May 1, 2018
Adjuvant therapy for advanced renal cell carcinomaMatthew A Meissner, Barrett Z McCormick, Jose A Karam, et al.Expert Review of Anticancer Therapy|April 28, 2017
The role of adhesions between homologous cancer cells in tumor progression and targeted therapyJie Xia, Yuhao Cheng, Hang Zhang, et al.Expert Review of Anticancer Therapy|June 1, 2019
Targeting the tumor microenvironment in pancreatic ductal adenocarcinomaVeethika Pandey, Peter StorzExpert Review of Anticancer Therapy|April 18, 2019
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?Mehran Afshar, Hiten R H Patel, Ankit Jain, et al.Expert Review of Anticancer Therapy|March 19, 2022
Ribociclib efficacy in special populations and analysis of patient-reported outcomes in the MONALEESA trialsMaria V Sanò, Federica Martorana, Giuseppe Lavenia, et al.Expert Review of Anticancer Therapy|March 8, 2022
Diagnostic significance of miRNAs as potential biomarkers for human renal cell carcinoma: a systematic review and meta-analysisYiwei Gu, Jiuhong YuanExpert Review of Anticancer Therapy|January 29, 2021
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancersAlistair M Cook, Alison McDonnell, Michael J Millward, et al.Pageof 310